Free Trial

Onconetix (ONCO) Stock Price, News & Analysis

Onconetix logo
$2.89
-0.07 (-2.36%)
(As of 10/31/2024 ET)

About Onconetix Stock (NASDAQ:ONCO)

Key Stats

Today's Range
$2.85
$3.00
50-Day Range
$2.96
$6.38
52-Week Range
$2.82
$21.40
Volume
56,346 shs
Average Volume
331,432 shs
Market Capitalization
$64.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Onconetix Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
31st Percentile Overall Score

ONCO MarketRank™: 

Onconetix scored higher than 31% of companies evaluated by MarketBeat, and ranked 859th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Percentage of Shares Shorted

    0.31% of the float of Onconetix has been sold short.
  • Short Interest Ratio / Days to Cover

    Onconetix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Onconetix has recently decreased by 94.59%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Onconetix does not currently pay a dividend.

  • Dividend Growth

    Onconetix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.31% of the float of Onconetix has been sold short.
  • Short Interest Ratio / Days to Cover

    Onconetix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Onconetix has recently decreased by 94.59%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Onconetix has a news sentiment score of 1.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Onconetix this week, compared to 0 articles on an average week.
  • Search Interest

    Only 4 people have searched for ONCO on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Onconetix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.50% of the stock of Onconetix is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 23.89% of the stock of Onconetix is held by institutions.

  • Read more about Onconetix's insider trading history.
Receive ONCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Onconetix and its competitors with MarketBeat's FREE daily newsletter.

ONCO Stock News Headlines

The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
What's Going On With Onconetix Shares Friday?
Onconetix, Inc. (J4T.MU)
Onconetix, Inc. (J4T.F)
See More Headlines

ONCO Stock Analysis - Frequently Asked Questions

Onconetix's stock was trading at $7.92 at the beginning of the year. Since then, ONCO stock has decreased by 63.3% and is now trading at $2.91.
View the best growth stocks for 2024 here
.

Onconetix, Inc. (NASDAQ:ONCO) issued its quarterly earnings data on Thursday, August, 29th. The company reported ($9.20) EPS for the quarter. The business earned $0.71 million during the quarter.

Shares of Onconetix reverse split on Tuesday, September 24th 2024. The 1-40 reverse split was announced on Friday, September 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of ONCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Onconetix investors own include QUALCOMM (QCOM), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID), Plug Power (PLUG) and Sirius XM (SIRI).

Company Calendar

Last Earnings
8/29/2024
Today
10/31/2024
Next Earnings (Estimated)
11/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONCO
Previous Symbol
NASDAQ:ONCO
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-37,410,000.00
Pretax Margin
-3,635.62%

Debt

Sales & Book Value

Annual Sales
$1.46 million
Book Value
$3.01 per share

Miscellaneous

Free Float
730,000
Market Cap
$64.97 million
Optionable
N/A
Beta
3.65
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ONCO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners